Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program-Reference-Cited by-同舟云学术

Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program

Published:2017-04-24 Issue:1 Volume:48 Page:36-44
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Karchava Marine¹²,Chkhartishvili Nikoloz¹,Sharvadze Lali¹²³,Abutidze Akaki¹²,Dvali Natia¹,Gatserelia Lana¹²,Dzigua Lela¹,Bolokadze Natalia¹³,Dolmazashvili Ekaterine¹²³,Kotorashvili Adam⁴,Imnadze Paata⁴,Gamkrelidze Amiran⁴,Tsertsvadze Tengiz¹²³

Affiliation:

1. Infectious Diseases; AIDS and Clinical Immunology Research Center; Tbilisi Georgia

2. Hepatology Clinic- Hepa; Tbilisi Georgia

3. Ivane Javakhishvili Tbilisi State University; Tbilisi Georgia

4. National Center for Diseases Control and Public Health; Tbilisi Georgia

Funder

Department of Public Health and Human Services, National Center for Diseases Control and Prevention

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12890/fullpdf

Reference27 articles.

1. High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: recommendations for testing and treatment;Karchava;Hepatol Res.,2015

2. Discrepancy between HCV structural and non structural genes in Georgian genotype two patients;Tsertsvadze;Georgian Med News,2014

3. A natural intergenotypic recombinant of hepatitis C virus identified in St;Kalinina;Petersburg J Virol,2002

4. Serendipitous identification of natural intergenotypic recombinants of hepatitis C in Ireland;Moreau;Virol J,2006

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C Virus RF1_2k/1b Chimeras and a “Many Probes/One Spot” Approach to Their Identification;Russian Journal of Bioorganic Chemistry;2022-02

2. National Hepatitis C Elimination Program of Georgia;Hepatitis C: Epidemiology, Prevention and Elimination;2021

3. Assessment of treatment options for patients with hepatitis C virus recombinant form 2k/1b;Hepatology Research;2020-12-11

4. Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia;BMC Infectious Diseases;2020-01-10

5. Successful direct-acting antiviral treatment of three patients with genotype 2/1 recombinant hepatitis C virus;Clinical Journal of Gastroenterology;2018-11-16